Literature DB >> 29922614

The Prevalence of Virulence Genes and Virulotypes of Escherichia coli Strains Isolated from Hospital Wastewaters in Tehran, Iran.

Reza Ranjbar1, Omid Farahani2.   

Abstract

BACKGROUND: Due to the widespread different pathogenic strains, Escherichia coli lead many severe to normal diseases worldwide. Finding the relation of clones with genomic content and clinical features is a key point to recognize the high potential-invasive strains. Specific virulence factors include adhesions, invasions, toxins, and capsule are the main determinants of pathogenic factors of E. coli strains.
METHODS: From Jun 2014 to Jun 2016, E. coli isolates recovered using standard bacteriological methods from wastewater sources in different hospitals in Tehran, Iran, were monitored to recognize the virulence genes by polymerase chain reaction (PCR) assay.
RESULTS: The high and low presences of virulence factors were fimH, 76% and afa, 13%, respectively.
CONCLUSION: The results indicated the potential pathogenicity of E. coli strains circulating in hospital wastewaters in Tehran, Iran.

Entities:  

Keywords:  Escherichia coli; Hospital wastewater; Virulence factors

Year:  2018        PMID: 29922614      PMCID: PMC6005981     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

As one of the main sources of risk issues related to public health, there is an increasing concern about water contaminations despite recent development in the field of water treatment technologies (1). Coastal zones with the high percentage of untreated sewage injected into waters play a significant role in terms of pollution formation supposed to be the main cause for the greatest number of public health hazard worldwide (2–4) containing waterborne severe diseases and infections like typhoid fever, cholera, dysentery and traveller’s diarrhea, caused by different types of bacterial pathogens (5). Expanding the spectrum of waterborne infections (6), lack of regular monitoring of waterborne pathogens, as well as accurate and cost-effective diagnostic tests, are the major issues required to be concerned in order to protect public health, prevent and control the infections transmitted by waterborne pathogens. The presence of E. coli in a variety of infections (7–9), and its diverse clinical spectrum ranging from asymptomatic bacteriuria (reported to have a prevalence of 4%–6% in young women and up to 20% in elderly women (10, 11)) to acute cystitis to pyelonephritis is considered as one of the most common troublesome medicinal issue in an extensive variety of countries all around the world. The complex pathogenesis analyses are infected by both the host biological and behavioral, and the virulence characteristics of the infecting uropathogenic (12). Its propensity to rehash and the certifiable test posed to practical chemotherapy make it worth focus on the virulence repertoire of E. coli strains isolated from infected samples. The range of well-recognized virulence factors (VF), for instance, fimbrial and afimbrial adhe-sins, toxins and siderophores and new potential ones have been implicated to E. coli strains to agitate the host prosperity congruity (13). Many genes are involved, which means that interaction of various virulence genes with host immune system resulted in infection. The exact role of most virulence determinants, however, is still not clearly known in many infection pathogenesis (14). Conventional methods for detection of E. coli based on culturing were time-consuming and not enough efficient in order to identification of pathogenic strains. Improvement of molecular technology has conducted apprehensive studies in the field of uropathogenic E. coli (8, 12, 15–24). The convenient and rapid approach of polymerase chain reaction (PCR) leads to figure out an outstanding assessment of virulence determinants detected which may be useful for diagnosis applications and therapeutic strategies (25–28). Unfortunately, despite the importance of uropathogenic E. coli, few studies have been performed for monitoring of uropathogenic E. coli especially in waters and wastewaters samples (29). Recent studies are carried out interested to assess the prevalence of different operons coding for virulence factors among E. coli strains isolated from various samples from different sources and establish the data bank containing the molecular characteristics of E. coli strains to circulate in different countries. In the present study, E coli isolates from wastewater sources of different hospitals in Tehran, Iran, were monitored to recognize the virulence genes by polymerase chain reaction (PCR) assay.

Materials and Methods

Sample collection and processing

E. coli strains isolated from hospital wastewater sources over a 24-months sampling period (Jun 2014–Jun 2016) were included in the study. For further analysis, sampling bottles were shipped to the Laboratory in Molecular Biology Research Center, Baqiyatallah, Tehran, Iran. Standard Methods for the Examination of Water and Wastewater 22nd edition were used as the basic methods for culture-based tests (30). All samples were analyzed for the presence of E. coli. E. coli colonies from agar plates were picked and streaked for purity on EMB agar. Well-isolated colonies of purified E. coli were stored for long-term storage in SKIM Milk media with 20% (v/v) glycerol and at −20 colThe E. coli strains were isolated by minimal standard bacteriological test and identified compared with the E. coli laboratory reference using conventional biochemical tests.

PCR

E. coli isolates were tested for the presence of specific primers used to amplify sequences of the type 1 fimbriae (fimH), pili associated with pyelonephritis (pap), S fimbriae (sfa), afimbrial adhesins (afa), hemolysin (hly), and cytotoxic necrotizing factor (cnf), aerobactin (aer). Details of primer sequences, predicted sizes of the amplified products and specific annealing temperatures are given in Table 1.
Table 1:

Characteristics of primer sequences used for PCR assays

Virulence factorTarget gene(s)Primer sequence (5′-3′)Size fragment (bp)
Tape 1 fimbriaefimHF:GAGAAGAGGTTTGATTTAACTTATTGR:AGAGCCGCTGTAGAACTGAGG559
P fimbriaepapF:GACGGCTGTACTGCAGGG TGTGGCGR:ATATCCTTTCTGCAGGGATGCAATA328
Afa adhesinsafaF:GCTGGGCAGCAAACTGATAAC TCTCR:CATCAAGCTGTTTGTTCGTCCGCCG750
HaemolysinhlyAF:AACAAGGATAAGCACTGTTCTGGCTR:ACCATATAAGCGGTCATTCCCGTCA1177
Cytotoxic necrotizing factorcnfF:TTATATAGTCGTCAAGATGGAR:CACTAAGCTTTACAATATTGA639
AerobactinaerF:TACCGGATTGTCATATGCAGACCGTR:AATATCTTCCTCCAGTCCGGAGAAG602
Characteristics of primer sequences used for PCR assays Detection of sequences of target genes was done by PCR (31). PCR amplification of bacterial DNA extracts was performed in 20 μl of template DNA (1 μl), 10 pmoles of each primer, the four deoxynucleoside triphosphates (each at 10 μM) and 1.25 U Taq DNA polymerase in 2x PCR buffer containing MgCl2. For finding the optimum amplification procedure, the denaturation and annealing conditions were described in Table 2. The final reaction mixture (6μl) underwent gel electrophoresis in 1.5% agarose containing in 100 ml TBE (1X) buffer (1,6 M Tris-EDTA, 0,02 M boric acid) per ml. Amplified DNA fragments of specific sizes were detected by UV induced fluorescence. Overall, 1000 bp DNA ladder (Viogene) was used for determining the sizes of the amplicons.
Table 2:

PCR conditions of target genes

GenesInitial denaturation (°C/min)Denaturation (°C/s)Annealing (°C/s)Extension (°C/s)Final extension (°C/min)
fimH95/594/6059/6072/6072/7
pap95/594/6063/6072/6072/7
afa95/594/6065/6072/6072/7
hlyA95/594/6062/6072/6072/7
cnf95/594/6057/6072/6072/7
aer95/594/6068/6072/6072/7
PCR conditions of target genes The amplified DNA product was visualized by standard submarine gel electrophoresis using 10 μL of the final reaction mixture on a 2% agarose gel. Amplified DNA fragments of specific sizes were located by UV fluorescence, after staining with ethidium bromide. The 100-bp ladder was used as a standard for determining molecular size of PCR products (Fig. 1).
Fig. 1:

Detection of fimH (559 bp), aer (602 bp), pap (328 bp), and afa (750 bp) gene by PCR in hospital wastewaters. Lane 5 and 6: negative representative hlyA and cnf genes

Detection of fimH (559 bp), aer (602 bp), pap (328 bp), and afa (750 bp) gene by PCR in hospital wastewaters. Lane 5 and 6: negative representative hlyA and cnf genes

Results

Eighty strains of E. coli were isolated from hospital wastewater sources and subjected to PCR assay in order to determine the prevalence of virulence genes. The frequencies and profiles of virulence genes are shown in Table 3 and 4, respectively. The prevalence of genes of fimbrial adhesive systems was 76% and 16% for fimH, and pap, respectively. Afa afimbrial adhesins were detected in 13% of strains. The prevalence of 53% was identified for the aer gene. The presence of two genes encoding toxins, i.e. hly and cnf were not detected. Sixty-one strains shared DNA sequences related to fimH and other genes associated as aer, pap, and afa. FimH adhesin was the most prevalent virulence factor detected, having occurred in 76% of strains, and it was detected in 16% of operon pap. The studied strains of the total fimH showed adhesin-encoding operon fimH (95%), fimH-afa (20%), fimH-afa-pap (2.5%) and fimH-pap (1.2%) and 51 of them showed the other VF gene: Aer- fimH (47%), Aer- fimH-afa (6.2%) and Aer- fimH-pap (10%) (Table 4). The high presence of adhesion genes and the low presence of genes encoding toxins were illustrated in our finding.
Table 3:

Frequency of virulence genes among 80 E. coli isolates

Virulence geneTotal (n = 80), n (%)
fimH61(76)
aer43(53)
Pap13(16)
afa11(13)
hlyA0 (0)
cnf0 (0)
Table 4:

Nine different patterns for virulence gene profiles

Profile namesVirulence gene patternsTotal (n = 80), n (%)
[Type 1]fimH-afa16 (20)
[Type 2]fimH-afa-pap2 (2.5)
[Type 3]afa-pap2(2.5)
[Type 4]fimH-pap1(1.2)
[Type 5]Aer- fimH38(47)
[Type 6]Aer- fimH-afa5(6.2)
[Type 7]Aer- fimH-pap8(10)
[Type 8]Aer- afa5(6.2)
[Type 9]Aer-pap8(10)
Frequency of virulence genes among 80 E. coli isolates Nine different patterns for virulence gene profiles

Discussion

Finding the relation of genetic virulence traits of the clinical isolates and the type of infections will influence the treatment of these infections. Adhesins, toxins and iron-chelating factors (siderophores) were reported as the main virulence factors (VFs) of E. coli (32) while afimbrial adhesins (afa), pfimbrial adhesins (pap) and s-fimbrial adhesins (sfa) were indicated as those adhesins by which UPEC typically attach to epithelial cells lining (33). Intimin, as one of the pathogenic factor, was playing an important role in virulence helping bacteria to attach the epithelial cell lining (28, 34). A recent research about cytotoxic necrotizing and haemolytic factors was conducted (18). Forty percent of UPEC produce cytotoxic necrotizing factor 1(cnf1) involved in the dissemination and persistence of cells in the urinary tract. Aerobactin, the iron chelating agent, encoded by aer have been reported as a determinate factor to enabling colonization of E. coli in iron-poor environments (35). Promotion of bacterial invasion through the epithelial barrier is considered due to the cytolytic effect of α-hemolysin (hlyA) encoded by α-hly. In this study, the high percentage of adhesins gene could be related to the pathogenicity of the isolated strains as adherence is the most important pathogenicity determinant (36). fimH was highly conserved in UTI isolates, which confirms its crucial role during colonization of the urinary tract (36–39). The presence of pap gene had been considered in association with pyelonephritis; therefore, lower percentages of pap gene (16%) may propose the lower capabilities of isolated strains to colonize kidneys and generate pyelonephritis (40, 41). The hlyA and cnf genes indicated the positive relationship with pathogenicity island PAI IIJ96, and the pathogenicity island PAI ICFT073 is related to aer gene as well as with hlyA and pap operon (42–46). Molecular methods particularly DNA-based detection techniques help us help us in the field of diagnostic and molecular epidemiology of pathogenic microbial strains (47–48). The technique used in current study was able of to elucidate successfully the pathogenicity status of the strains under the study.

Conclusion

Consequently, we represent the high frequency of fimH gene among isolated strains of E. coli from wastewater samples followed by new patterns of frequencies in association with virulence genes of aer, pap, afa, and fimH. PCR typing acts as a useful method to determine the virulence gene profiles of E. coli strains and detect the complete data from genome content in association with different E. coli strains that may cause severe illnesses worldwide. The high percent of virulence genes of E. coli strains circulating in hospital wastewaters indicated a warning danger for the transfer of these genes to the environment. Therefore, immediate measures are needed to control and treat hospital wastewaters more effectively.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been considered by the authors.
  42 in total

Review 1.  Secreted proteins and other features specific to uropathogenic Escherichia coli.

Authors:  D M Guyer; N W Gunther ; H L Mobley
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 2.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

Review 3.  Typing methods used in the molecular epidemiology of microbial pathogens: a how-to guide.

Authors:  Reza Ranjbar; Ali Karami; Shohreh Farshad; Giovanni M Giammanco; Caterina Mammina
Journal:  New Microbiol       Date:  2014-01-15       Impact factor: 2.479

4.  Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains.

Authors:  Martine Bingen-Bidois; Olivier Clermont; Stéphane Bonacorsi; Mustapha Terki; Naïma Brahimi; Chawki Loukil; Dominique Barraud; Edouard Bingen
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 5.  Waterborne protozoan pathogens.

Authors:  M M Marshall; D Naumovitz; Y Ortega; C R Sterling
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  A prospective study of asymptomatic bacteriuria in sexually active young women.

Authors:  T M Hooton; D Scholes; A E Stapleton; P L Roberts; C Winter; K Gupta; M Samadpour; W E Stamm
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

Review 7.  Structural biology of bacterial iron uptake systems.

Authors:  T E Clarke; L W Tari; H J Vogel
Journal:  Curr Top Med Chem       Date:  2001-05       Impact factor: 3.295

8.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.

Authors:  B Foxman; L Zhang; P Tallman; K Palin; C Rode; C Bloch; B Gillespie; C F Marrs
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

9.  Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections.

Authors:  C Le Bouguenec; M I Garcia; V Ouin; J M Desperrier; P Gounon; A Labigne
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 10.  Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes.

Authors:  Nadia Jahandeh; Reza Ranjbar; Payam Behzadi; Elham Behzadi
Journal:  Cent European J Urol       Date:  2015-11-27
View more
  1 in total

Review 1.  Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review.

Authors:  Mehrdad Halaji; Amirhossein Fayyazi; Mehdi Rajabnia; Donya Zare; Abazar Pournajaf; Reza Ranjbar
Journal:  Front Cell Infect Microbiol       Date:  2022-02-25       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.